首页 | 本学科首页   官方微博 | 高级检索  
   检索      

Following a TRAIL: Update on a ligand and its five receptors
作者姓名:Kimberley FC  Screaton GR
作者单位:[1]WeatherallInstituteofMolecularMedicine,HumanImmunologyUnit,JohnRadcliffeHospital,OxfordOX39DS,UK [2]DepartmentofMedicine,HammersmithHospital,ImperialCollege,DuCaneRoad,LondonW12ONNUK
摘    要:Identification of tumour necrosis factor apoptosis inducing ligand (TRAIL), a TNF family ligand, sparked a torrent of research, following an initial observation that it could kill tumour cells, but spare normal cells. Almost a decade after its discovery, and with five known receptors, the true physiological role of TRAIL is still debated and its anti-tumorigenic properties limited by potential toxicity. This review takes a comprehensive look at the story of this enigmatic ligand,addressing its remaining potential as a therapeutic and providing an overview of the TRAIL receptors themselves.

关 键 词:肿瘤坏死因子细胞凋亡诱导配位子  受体  癌症  细胞凋亡  治疗

Following a TRAIL: update on a ligand and its five receptors
Kimberley FC,Screaton GR.Following a TRAIL: update on a ligand and its five receptors[J].Cell Research,2004,14(5):359-372.
Authors:Kimberley Fiona C  Screaton Gavin R
Institution:Department of Medicine, Hammersmith Hospital, Imperial College, Du Cane Road, London, UK.
Abstract:Identification of tumour necrosis factor apoptosis inducing ligand (TRAIL), a TNF family ligand, sparked a torrent of research, following an initial observation that it could kill tumour cells, but spare normal cells. Almost a decade after its discovery, and with five known receptors, the true physiological role of TRAIL is still debated and its anti-tumorigenic properties limited by potential toxicity. This review takes a comprehensive look at the story of this enigmatic ligand, addressing its remaining potential as a therapeutic and providing an overview of the TRAIL receptors themselves.
Keywords:TRAIL  apoptosis  cancer  
本文献已被 CNKI 维普 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号